Peconic Partners’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
Sell
-32,798
Closed -$7.84M 64
2017
Q1
$7.84M Buy
+32,798
New +$7.64M 0.9% 17
2016
Q3
Sell
-142,860
Closed -$33M 50
2016
Q2
$33M Buy
142,860
+122,880
+615% +$28.3M 4.1% 4
2016
Q1
$5.36M Buy
+19,980
New +$5.72M 1.16% 17
2015
Q3
Sell
-81,110
Closed -$24.6M 45
2015
Q2
$24.6M Sell
81,110
-17,600
-18% -$5.25M 3.98% 9
2015
Q1
$29.4M Buy
98,710
+22,710
+30% +$6.47M 4.57% 7
2014
Q4
$19.6M Buy
+76,000
New +$19M 4.25% 10

Other funds holding AGN

Peconic Partners's AGN Position: Q2 2017 in Review

Peconic Partners sold out of Allergan plc (AGN) in Q2 2017, closing a stake of 32,798 shares — an estimated $7.84M sold.

Peconic Partners first reported a position in AGN in Q4 2014 and held it in 6 quarters. The position peaked at $33M in Q2 2016. 1,115 funds tracked by Wall St. Rank hold AGN as of Q2 2017.

  • Peconic Partners reported no remaining Allergan plc position as of Q2 2017 after selling out during the quarter.
  • Peconic Partners sold 32,798 Allergan plc shares in Q2 2017, an estimated $7.84M.
  • Peconic Partners first reported a position in Allergan plc in Q4 2014 and held it in 6 quarters.
  • Peconic Partners's Allergan plc position peaked at $33M in Q2 2016.
  • 1,115 funds tracked by Wall St. Rank held Allergan plc as of Q2 2017.

Based on Peconic Partners's 13F filing for Q2 2017, filed 14 Aug 2017.